Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease.
CONCLUSIONS: We developed a new preclinical model of Group2-PH by combining MetS with LHD. We showed that MetS exacerbates Group 2 PH. We provided evidence for the importance of the IL-6-STAT3 pathway in our experimental model of Group2-PH and human patients.
PMID: 31154939 [PubMed - as supplied by publisher]
Source: Circulation Research - Category: Cardiology Authors: Ranchoux B, Nadeau V, Bourgeois A, Provencher S, Tremblay E, Omura J, Côté N, Abu-Alhayja'a R, Dumais V, Nachbar RT, Tastet L, Dahou A, Breuils-Bonnet S, Marette A, Pibarot P, Dupuis J, Boucherat O, Paulin R, Archer SL, Bonnet S, Potus F Tags: Circ Res Source Type: research
More News: Cardiac Catheterization | Cardiology | Diets | Fortamet | Heart | Heart Disease | High Fat | Hypertension | Metabolic Syndrome | Metformin | Nutrition | Pulmonary Artery Catheterization | Pulmonary Hypertension | Zyprexa